CK 103A

interleukin-1 antagonist; structure in first source

Also Known As:

CK-103A

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Uveitis 10/01/1997 - "Because of the discovery of potent interleukin-1 (IL-1) blocking effects by CK-103A (4,6-dihydropyridazino[4,5-c]pyridazin-5 (1H)-ones) on rat uveitis induced by IL-1, numerous derivatives of CK-103A have been synthesized and their efficacies on the same animal model studied. "

1.	Interleukin-1 (Interleukin 1)